30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Nextremity Solutions Gains Clearance for Lesser TMT Joint Arthrodesis System -

Nextremity Solutions received FDA 510(k) clearance to market the InCore® TMT system, a three-part construct for fixation for internal fixation for Lesser Tarsometatarsal Joint Arthrodesis (also known as Lisfranc Joint Fusion or 2nd/3rd Tarsometatarsal Fusion). This new system applies aspects of InCore Lapidus, including the solid intraosseous fixation construct aimed to minimize hardware prominence.